Chemours (NYSE: CC) reported Q3 EPS of $0.63, $0.07 worse than the analyst estimate of $0.70. Revenue for the quarter came in at $1.5 billion versus the consensus estimate of $1.52 billion.

For earnings history and earnings-related data on Chemours (CC) click here.